{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:31:46Z","timestamp":1793640706749,"version":"4.5.1"},"reference-count":16,"publisher":null,"issue":"4","license":[{"start":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/lib.ossn.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kardiologiia"],"abstract":"<jats:p>In recent years there has been significant interest in treating iron deficiency (ID) in patients with heart failure (HF) due to its high prevalence and detrimental effects in this population. As stated in the 2020 Russain HF guidelines, Intravenous ferric carboxymaltose remains the only proven therapy for ID.This document was prompted by the results from the recent AFFIRM-AHF trial which demonstrates that treatment of ID after acute HF decompensation reduces the risk of future decompensations.\u00a0Experts have concluded that in HF patients with acute decompensation, a left ventricular ejection fraction of &lt; 50% and ID, Intravenous ferric carboxymaltose reduces future HF hospitalisations. Patients with stable HF may also benefit from treatment of ID to improve quality of life and alleviate symptoms. \u00a0It is, therefore, reasonable to screen for and treat ID in patients with HF.<\/jats:p>","DOI":"10.18087\/cardio.2021.4.n1639","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T07:35:40Z","timestamp":1621236940000},"page":"73-78","source":"Crossref","is-referenced-by-count":8,"title":["Expert consensus regarding treatment of iron deficiency in stable and decompensated patients with heart failure"],"prefix":"10.68900","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1939-7189","authenticated-orcid":true,"given":"Yu. V.","family":"Mareev","sequence":"first","affiliation":[{"name":"National Medical Research Centre for Therapy and Preventive Medicine, Moscow, Russia\r\nRobertson Centre for Biostatistics, Glasgow, Great Britain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. R.","family":"Gilarevsky","sequence":"additional","affiliation":[{"name":"Russian Medical Academy of Postgraduate Education, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7992-6081","authenticated-orcid":true,"given":"Yu. L.","family":"Begrambekova","sequence":"additional","affiliation":[{"name":"Medical Research and Educational Center of the M. V. Lomonosov Moscow State University, Moscow, Russia\r\nFaculty of Fundamental Medicine, Lomonosov Moscow State University, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu. M.","family":"Lopatin","sequence":"additional","affiliation":[{"name":"Volgograd State Medical University, Volgograd, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Garganeeva","sequence":"additional","affiliation":[{"name":"Research Institute for Cardiology, Siberian State Medical University, Tomsk National Research Medical Center, Russian Academy of Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6453-2976","authenticated-orcid":true,"given":"D. V.","family":"Duplyakov","sequence":"additional","affiliation":[{"name":"Samara Regional Clinical Cardiological Dispensary, Russia\r\nSamara State Medical University, Samara, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5873-1768","authenticated-orcid":true,"given":"Zh. D.","family":"Kobalava","sequence":"additional","affiliation":[{"name":"Russian State University of Peoples' Friendship, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6252-0322","authenticated-orcid":true,"given":"E. Z.","family":"Golukhova","sequence":"additional","affiliation":[{"name":"Bakulev National Medical Research Center of Cardiovascular Surgery, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7003-5186","authenticated-orcid":true,"given":"N. A.","family":"Koziolova","sequence":"additional","affiliation":[{"name":"Perm State Medical University named after Academician E.A. Wagner, Perm, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0410. V.","family":"Panov","sequence":"additional","affiliation":[{"name":"V.A. Almazov National Medical Research Center, Saint Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0422. \u0410.","family":"Lelyavina","sequence":"additional","affiliation":[{"name":"V.A. Almazov National Medical Research Center, Saint Petersburg, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4453-8430","authenticated-orcid":true,"given":"O. M.","family":"Drapkina","sequence":"additional","affiliation":[{"name":"National Medical Research Centre for Therapy and Preventive Medicine, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7285-2048","authenticated-orcid":true,"given":"V. Yu.","family":"Mareev","sequence":"additional","affiliation":[{"name":"Medical Research and Educational Center of the M. V. Lomonosov Moscow State University, Moscow, Russia\r\nFaculty of Fundamental Medicine, Lomonosov Moscow State University, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":null,"published-online":{"date-parts":[[2021,5,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Mareev V.Yu., Gilyarevskiy S.R., Mareev Yu.V., Begrambekova Yu.L., Belenkov Yu.N., Vasyuk Yu.A. et al. Position Paper. The role of iron deficiency in patients with chronic heart failure and current corrective approaches. Kardiologiia. 2020;60(1):99\u2013106. DOI: 10.18087\/cardio.2020.1.n961","DOI":"10.18087\/cardio.2020.1.n961"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Mareev V.Yu., Fomin I.V., Ageev F.T., Begrambekova Yu.L., Vasyuk Yu.A., Garganeeva A.A. et al. Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment. Kardiologiia. 2018;58(6S):8\u2013158. DOI: 10.18087\/cardio.2475","DOI":"10.18087\/cardio.2475"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016;37(27):2129\u2013200. DOI: 10.1093\/eurheartj\/ehw128","DOI":"10.1093\/eurheartj\/ehw128"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Tereshchenko S.N., Galyavich A.S., Uskach T.M., Ageev F.T., Arutyunov G.P., Begrambekova Yu.L. et al. 2020 Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2020;25(11):311\u201374. DOI: 10.15829\/1560-4071-2020-4083","DOI":"10.15829\/1560-4071-2020-4083"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Ebner N, von Haehling S. Why is Iron Deficiency Recognised as an Important Comorbidity in Heart Failure? Cardiac Failure Review. 2019;5(3):173\u20135. DOI: 10.15420\/cfr.2019.9.2","DOI":"10.15420\/cfr.2019.9.2"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. European Heart Journal. 2010;31(15):1872\u201380. DOI: 10.1093\/eurheartj\/ehq158","DOI":"10.1093\/eurheartj\/ehq158"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Chopra VK, Anker SD. Anaemia, iron deficiency and heart failure in 2020: facts and numbers. ESC heart failure. 2020;7(5):2007\u201311. DOI: 10.1002\/ehf2.12797","DOI":"10.1002\/ehf2.12797"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H et al. Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency. New England Journal of Medicine. 2009;361(25):2436\u201348. DOI: 10.1056\/NEJMoa0908355","DOI":"10.1056\/NEJMoa0908355"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. European Heart Journal. 2015;36(11):657\u201368. DOI: 10.1093\/eurheartj\/ehu385","DOI":"10.1093\/eurheartj\/ehu385"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Lewis GD, Malhotra R, Hernandez AF, McNulty SE, Smith A, Felker GM et al. Effect of Oral Iron Repletion on Exercise Capacity in Patients with Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial. JAMA. 2017;317(19):1958\u201366. DOI: 10.1001\/jama.2017.5427","DOI":"10.1001\/jama.2017.5427"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Ponikowski P, Kirwan B-A, Anker SD, McDonagh T, Dorobantu M, Drozdz J et al. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet (London, England). 2020;396(10266):1895\u2013904. DOI: 10.1016\/S0140-6736(20)32339-4","DOI":"10.1016\/S0140-6736(20)32339-4"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Van Veldhuisen DJ, Ponikowski P, van der Meer P, Metra M, B\u00f6hm M, Doletsky A et al. Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency. Circulation. 2017;136(15):1374\u201383. DOI: 10.1161\/CIRCULATIONAHA.117.027497","DOI":"10.1161\/CIRCULATIONAHA.117.027497"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Anker SD, Kirwan B-A, van Veldhuisen DJ, Filippatos G, Comin-Colet J, Ruschitzka F et al. Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis: Outcomes in iron-deficient heart failure patients. European Journal of Heart Failure. 2018;20(1):125\u201333. DOI: 10.1002\/ejhf.823","DOI":"10.1002\/ejhf.823"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Bhatt DL, Szarek M, Steg PG, Cannon CP, Leiter LA, McGuire DK et al. Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure. The New England Journal of Medicine. 2021;384(2):117\u201328. DOI: 10.1056\/NEJMoa2030183","DOI":"10.1056\/NEJMoa2030183"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J et al. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. The New England Journal of Medicine. 2020;382(20):1883\u201393. DOI: 10.1056\/NEJMoa1915928","DOI":"10.1056\/NEJMoa1915928"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Teerlink JR, Diaz R, Felker GM, McMurray JJV, Metra M, Solomon SD et al. Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure. New England Journal of Medicine. 2021;384(2):105\u201316. DOI: 10.1056\/NEJMoa2025797","DOI":"10.1056\/NEJMoa2025797"}],"container-title":["Kardiologiia"],"original-title":[],"link":[{"URL":"https:\/\/lib.ossn.ru\/jour\/article\/viewFile\/1639\/970","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:17:53Z","timestamp":1793639873000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardio.elpub.ru\/jour\/article\/view\/1639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":16,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,5,6]]}},"URL":"https:\/\/doi.org\/10.18087\/cardio.2021.4.n1639","relation":{},"ISSN":["2412-5660","0022-9040"],"issn-type":[{"value":"2412-5660","type":"electronic"},{"value":"0022-9040","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,6]]}}}